A Monte Carlo study on the effect of seed design on the interseed attenuation in permanent prostate implants

Medical Physics

Volumn 35, Issue 8, 2008, Pages 3671-3681

  Afsharpour, Hossein ^a,b   D'Amours, Michel ^a,b   Coté, Benoit ^c   Carrier, Jean François ^d   Verhaegen, Frank ^e   Beaulieu, Luc ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATOMS; MONTE CARLO METHODS; RADIOTHERAPY; UROLOGY;

CLINICAL PARAMETERS; MEDICAL MODELING; ORGANS AT RISKS; PROSTATE IMPLANTS; SHIELDING EFFECT; STANDARD ALGORITHMS; SYSTEMATIC STUDY; TRANSPERINEAL INTERSTITIAL PERMANENT PROSTATE BRACHYTHERAPY;

ONCOLOGY;

ARTICLE; BRACHYTHERAPY; CALCULATION; ENCAPSULATION; GEOMETRY; IMPLANT; MONTE CARLO METHOD; PRIORITY JOURNAL; SIMULATION; VALIDATION PROCESS;

EID: 48349124498     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2955754     Document Type: Article

References (34)

1. A. Glicksman, " Radiobiologic basis of brachytherapy.," Semin Oncol. Nurs. 3, 3-6 (1987).
2. P. M. Devlin, Brachytherapy: Applications and Techniques (Lippincott Williams and Wilkins, Philadelphia, USA, 2006).
3. O. Pasteau and P. Degrais, " Traitment du cancer de la prostate par le Radium.," Rev. Mal. Nutr., 363-367 (1911).
4. B. H. Heintz, R. E. Wallace, and J. M. Havezi, " Comparison of I-125 sources used for permanent interstitial implants.," Med. Phys. 28, 671-682 (2001).
5. M. J. Rivard, B. M. Coursey, L. A. DeWerd, W. F. Hanson, M. S. Huq, G. S. Ibbot, M. G. Mitch, R. Nath, and J. F. Williamson, " Update of the AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.," Med. Phys. 31, 633-674 (2004).
6. M. J. Rivard, W. M. Butler, L. A. DeWerd, M. S. Huq, G. S. Ibbot, A. S. Meigooni, C. S. Melhus, M. G. Mitch, R. Nath, and J. F. Williamson, " Supplement to the 2004 update of the AAPM task group no. 43 report.," Med. Phys. 34, 2187-2205 (2007).
7. O. Chibani, J. F. Williamson, and D. Todor, " Dosimetric effects of seed anisotropy and interseed attenuation for Pd103 and I125 prostate implants.," Med. Phys. 32, 2557-2566 (2005).
8. Y. Yub, L. L. Anderson, Z. Li, D. E. Mellenberg, R. Nath, M. C. Schell, F. M. Waterman, A. Wu, and J. C. Blasko, " Permanent prostate seed implant brachytherapy: Report of the American Association of Physicists in Medicine Task Group No. 64.," Med. Phys. 26, 2054-2076 (1999).
9. J.-F. Carrier, L. Beaulieu, F. Therriault-Proulx, and R. Roy, " Impact of interseed attenuation and tissue composition for permanent prostate implants.," Med. Phys. 33, 595-604 (2006).
10. S. Agostinelli, Nucl. Instrum. Methods Phys. Res. A 506, 250-303 (2003).
11. J.-F. Carrier, L. Archambault, L. Beaulieu, and R. Roy, " Validation of Geant4, an object-oriented Monte Carlo toolkit, for simulations in medical physics.," Med. Phys. 31, 484-492 (2004).
12. E. Poon and F. Verhaegen, " Accuracy of the photon and electron physics in GEANT4 for radiotherapy applications.," Med. Phys. 32, 1696-1711 (2005).
13. E. Poon, J. Seuntjens, and F. Verhaegen, " Consistency test of the electron transport algorithm in the GEANT4 Monte Carlo code.," Phys. Med. Biol. 50, 681-694 (2002).
14. D. Cullen, The Evaluated Photon Data Library, 97 version (1997), UCRL-50400, Vol. 6, Rev 5. Lawrence Livermore National Laboratory, Livermore, CA.
15. S. Perkins, Table and Graphs of Electron Iteraction Cross Section from 10 eV to 100 eV Derived from the LLNL Evaluated Electron Data Library (EEDL) (1997), UCRL-50400, Vol. 31. Lawrence Livermore National Laboratory, Livermore, CA.
16. S. T. Perkins, Table and Graphs of Atomic Subshells and Relaxation Data Derived from the LLNL Evaluated Atomic Data Library (EADL), Z=1-100 (1997), UCRL-50400, Vol. 30. Lawrence Livermore National Laboratory, Livermore, CA.
17. A. S. Meigooni, Z. Bharucha, M. Yoe-Sein, and K. Swords, " Dosimetric characteristics of the Best double-wall Pd103 brachytherapy source.," Med. Phys. 28, 2568-2575 (2001).
18. S. W. Peterson and Bruce Thomadsen, " Measurements of the dosimetric constants for a new Pd103 brachytherapy source.," Brachytherapy 1, 110-119 (2002).
19. Z. Wang and N. E. Hertel, " Determination of dosimetric characteristics of OptiSeed a plastic brachytherapy Pd103 source.," Appl. Radiat. Isot. 63, 311-321 (2005).
20. S. Bernard and S. Vynckier, " Dosimetric study of a new polymer encapsulated palladium-103 seed.," Phys. Med. Biol. 50, 1493-1504 (2005).
21. A. S. Meigooni, M. M. Yoe-Sein, A. Y. Al-Otoom, and K. T. Sowards, " Determination of the dosimetric characteristics of InterSource iodine125 brachytherapy source.," Appl. Radiat. Isot. 56, 589-599 (2002).
22. B. Reniers, S. Vynckier, and P. Scalliet, " Dosimetric study of a new InterSource iodine125 seed.," Med. Phys. 28, 2285-2288 (2001).
23. M. J. Rivard, " Monte Carlo calculation of AAPM Task Group Report No. 43 dosimetry parameters for the MED3631-A/M I125 source.," Med. Phys. 28, 629-637 (2001).
24. Z. Li, J. J. Fan, and J. R. Palta, " Experimental measurements of dosimetric parameters on the transverse axis of a new I125 source.," Med. Phys. 27, 1275-1280 (2000).
25. R. E. Wallace and J. J. Fan, " Report on the dosimetry of a new design Iodine-125 brachytherapy source.," Med. Phys. 26, 1925-1931 (1999).
26. Z. Li, " Monte Carlo calculations of dosimetry parameters of the Urocor Prostaseed I125 source.," Med. Phys. 29, 1029-1034 (2002).
27. R. E. Wallace, " Empirical dosimetric characterization of a model I125-SL iodine125 brachytherapy source in phantom.," Med. Phys. 27, 2796-2802 (2000).
28. P. Karaiskos, P. Papagiannis, L. Sakelliou, G. Anagnostopoulos, and D. Baltas, " Monte Carlo dosimetry of the selectSeed I125 interstitial brachytherapy seed.," Med. Phys. 28, 1753-1760 (2001).
29. G. Anagnostopoulos, D. Baltas, P. Karaiskos, P. Sandilos, P. Papagiannis, and L. Sakelliou, " Thermoluminescent dosimetry of the selectSeed I125 interstitial brachytherapy seed.," Med. Phys. 29, 709-716 (2002).
30. J.-F. Carrier, M. D'Amours, F. Verhaegen, B. Reniers, A.-G. Martin, É. Vigneault, and L. Beaulieu, " Postimplant dosimetry using a Monte Carlo dose calculation engine: A new clinical standard.," Int. J. Radiat. Oncol., Biol., Phys. 68, 1190-1198 (2007).
31. L. Potters, " A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy.," Int. J. Radiat. Oncol., Biol., Phys. 50, 605-614 (2001).
32. R. G. Stock, " Postimplant dosimetry for I-125 prostate implants: Definitions and factors affecting outcome.," Int. J. Radiat. Oncol., Biol., Phys. 48, 899-906 (2000).
33. A. S. Meigooni, J. A. Meli, and R. Nath, " Interseed effects on dose for I125 brachytherapy implants.," Med. Phys. 19, 385-390 (1992).
34. P. Mobit and I. Badragan, " Dose perturbation effects in prostate seed implant brachytherapy with I-125.," Phys. Med. Biol. 49, 3171-3178 (2004).